Clinical Trial Update: Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI). [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the safety of intravenous amantadine hydrochloride (MR-301) in patients with severe traumatic brain injury; sponsored by SHINKEI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• amantadine hydrochloride (amantadine hydrochloride)

Snippet

Sponsor: SHINKEI Therapeutics, Inc | Conditions: Traumatic Brain Injury | Phase 2 | Status: ACTIVE_NOT_RECRUITING